Trial record 4 of 5 for: "Quadriplegia" | "Bronchodilator Agents"
24hr Effects of Tiotropium Bromide in Tetraplegia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02586649|
Recruitment Status : Enrolling by invitation
First Posted : October 26, 2015
Last Update Posted : March 5, 2018
James J. Peters Veterans Affairs Medical Center
Information provided by (Responsible Party):
Dr. Gregory Schilero, James J. Peters Veterans Affairs Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Enrolling by invitation|
|Estimated Primary Completion Date :||July 2018|
|Estimated Study Completion Date :||December 2018|
Publications of Results:
DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil. 1999 Nov;80(11):1411-9.
Spungen AM, Dicpinigaitis PV, Almenoff PL, Bauman WA. Pulmonary obstruction in individuals with cervical spinal cord lesions unmasked by bronchodilator administration. Paraplegia. 1993 Jun;31(6):404-7.
Almenoff PL, Alexander LR, Spungen AM, Lesser MD, Bauman WA. Bronchodilatory effects of ipratropium bromide in patients with tetraplegia. Paraplegia. 1995 May;33(5):274-7.